tirzepatide vs semaglutide appetite suppression vs. for Weight Loss Semaglutide vs tirzepatide for weight

Like the injectable weight-loss medications that came before it, Foundayo is in a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1s)

Overall, the median (Q1 to Q3) age of patients at baseline was 57 (49 to 65) years, 57% were female, 18% were Hispanic, 68% were White, 27% were Asian, and 0.6% were Black or African American

They'll also look at any current medications and health conditions to help set realistic goals and explore treatment options

The advent of novel pharmacologic weight loss approaches is changing the landscape for comorbidities such as diabetes, cardiovascular, and renal dysfunction in patients with obesity